Approximation to the Consumption of Healthcare Resources and the Economic Cost of SARS-CoV-2 Patient Management: A Retrospective Study.

COVID-19 SARS-CoV-2 coronavirus infections cost control and cost management health economics

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 26 12 2021
accepted: 02 02 2022
entrez: 18 4 2022
pubmed: 19 4 2022
medline: 20 4 2022
Statut: epublish

Résumé

Spain has become one of the countries most affected by coronavirus disease 2019 (COVID-19), with the highest testing rates, and one of the worst-performing countries in the fight against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. There are no studies related to the consumption of health resources and the economic cost of the SARS-CoV-2 virus. We present a retrospective analysis of 9,811 (Primary Care and Hospital) patients which aimed to estimate public health expenditure by the consumption of health resources due to COVID-19. According to the results, the gender distribution of patients has a similar rate in both groups, with slightly higher rates in women. Similarly, age is the same in both groups, with a median of 62 years in the case of hospitalizations and 61 years in the case of primary care; using a weighted average of these rates and costs, we can estimate that the average cost of care per patient infected with the SARS-CoV-2 virus, regardless of the course is €2373.24. We conclude that a patient with COVID-19 without hospitalization costs €729.79, while the expenses of a hospitalized patient are between €4294.36 and €14440.68, if there is ICU admission.

Identifiants

pubmed: 35433597
doi: 10.3389/fpubh.2022.843751
pmc: PMC9008573
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

843751

Informations de copyright

Copyright © 2022 Calderón-Moreno, Juárez-Vela, Delgado-Rodríguez, Quintana-Díaz, Magallón-Botaya, Olivan-Blázquez, Cobos-Rincón, Santolalla-Arnedo, Ramírez-Torres, Gea-Caballero and Andrés-Esteban.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Environ Res Public Health. 2021 Apr 06;18(7):
pubmed: 33917578
Rev Clin Esp. 2021 Aug-Sep;221(7):400-403
pubmed: 33288965
Gac Sanit. 2021 Jul-Aug;35(4):355-357
pubmed: 32354565
Lancet. 2020 Aug 22;396(10250):529-530
pubmed: 32771082
Rev Esp Anestesiol Reanim (Engl Ed). 2020 Oct;67(8):425-437
pubmed: 32800622
Front Public Health. 2020 Jul 03;8:347
pubmed: 32719765
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35
pubmed: 32232218
Curr Med Res Opin. 2021 Jan;37(1):27-36
pubmed: 33306421

Auteurs

Jesús Calderón-Moreno (J)

Business Economics Department, University of Rey Juan Carlos, Madrid, Spain.
Research Group Blood Patient Management, IDI-Paz Research Institute, Madrid, Spain.

Raúl Juárez-Vela (R)

Department of Nursing, GRUPAC, University of La Rioja, Logroño, Spain.

María Jesús Delgado-Rodríguez (MJ)

Business Economics Department, University of Rey Juan Carlos, Madrid, Spain.

Manuel Quintana-Díaz (M)

Research Group Blood Patient Management, IDI-Paz Research Institute, Madrid, Spain.
Intensive Care Unit, Research Group Blood Patient Management, IDI-Paz Research Institute, University Hospital "La Paz, " Madrid, Spain.

Rosa Magallón-Botaya (R)

Primary Care Prevention and Health Promotion Network, Research Unit in Primary Care, IIS Aragón, University of Zaragoza, Zaragoza, Spain.

Bárbara Olivan-Blázquez (B)

Department of Psychology and Sociology, Institute for Health Research Aragón (IISA), University of Zaragoza, Zaragoza, Spain.

Ana Cobos-Rincón (A)

Department of Nursing, GRUPAC, University of La Rioja, Logroño, Spain.

Iván Santolalla-Arnedo (I)

Department of Nursing, GRUPAC, University of La Rioja, Logroño, Spain.

Carmen Amaia Ramírez-Torres (CA)

Department of Nursing, GRUPAC, University of La Rioja, Logroño, Spain.

Vicente Gea-Caballero (V)

Research Group Blood Patient Management, IDI-Paz Research Institute, Madrid, Spain.
Faculty of Health Sciences, Valencia International University, Valencia, Spain.

Eva María Andrés-Esteban (EM)

Business Economics Department, University of Rey Juan Carlos, Madrid, Spain.
Research Group Blood Patient Management, IDI-Paz Research Institute, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH